Form 4: Varex Imaging Executive's Stock Activity Detailed
Insider Transaction Report
Varex Imaging SVP Andrew Hartmann reported vesting of restricted stock units, a new RSU grant, and shares withheld for taxes on December 10, 2025.
Summary
- Andrew Hartmann, Senior Vice President and General Manager of Detectors at Varex Imaging Corp (VREX), reported several transactions involving company stock and restricted stock units (RSUs) on December 10, 2025.
- 4,664 Restricted Stock Units granted on December 10, 2021, fully vested and converted into common stock.
- 7,935 Restricted Stock Units from a grant on December 10, 2023, vested, representing 50% of that specific grant.
- A new grant of 26,041 Restricted Stock Units was received by Mr. Hartmann.
- 3,636 shares of common stock were disposed of at a price of $11.7 per share to cover tax withholding obligations arising from the RSU vesting.
- Following these transactions, Mr. Hartmann directly beneficially owns 36,182 shares of Varex Imaging Corp common stock.
- Mr. Hartmann also beneficially owns 34,337 unvested Restricted Stock Units (7,936 from the 2023 grant and 26,401 from the new 2025 grant).
Sentiment
Score: 6
Explanation: The filing reports routine executive compensation activities, including RSU vesting and a new grant, which are generally positive for aligning management interests, offset by standard tax-related share disposals. No unexpected or negative events are indicated.
Positives
- Andrew Hartmann received a new grant of 26,041 Restricted Stock Units, aligning his long-term interests with those of shareholders.
- The vesting of previous RSU grants demonstrates the ongoing execution of the company's long-term incentive compensation plan for executives.
Negatives
- 3,636 shares of common stock were disposed of to satisfy tax withholding obligations, which is a standard practice but reduces direct common stock ownership.
Future Outlook
Future vesting schedules for Restricted Stock Units are outlined, with significant portions of the 2023 and 2025 RSU grants scheduled to vest on December 10, 2027, and the remaining portion of the 2025 RSU grant on December 10, 2029.
Industry Context
This Form 4 filing details routine insider transactions related to executive compensation, which is a common practice across publicly traded companies. It does not provide information on broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The RSU grants and vesting align executive incentives with shareholder value creation over the long term.
- Employees: Reflects standard executive compensation practices within the company.
Next Steps
- Delivery of vested shares to the reporting person upon vest dates.
- Future vesting of 7,936 Restricted Stock Units on December 10, 2027.
- Future vesting of 26,041 Restricted Stock Units, with 50% on December 10, 2027, and 50% on December 10, 2029.
Key Dates
| Date | Description |
|---|---|
| 12/10/2021 | Grant date for 4,664 Restricted Stock Units, which vested 50% on December 10, 2023, and 50% on December 10, 2025. |
| 12/10/2023 | Grant date for 7,935 Restricted Stock Units, which vested 50% on December 10, 2025, and are scheduled to vest 50% on December 10, 2027. |
| 12/10/2025 | Date of reported transactions, including vesting of RSUs, acquisition of common stock, disposal of common stock for taxes, and a new RSU grant. Also the grant date for 26,041 Restricted Stock Units. |
| 12/12/2025 | Signature date of the reporting person for the Form 4 filing. |
| 12/10/2027 | Scheduled vesting date for the remaining 50% of the 2023 RSU grant and the first 50% of the 2025 RSU grant. |
| 12/10/2029 | Scheduled vesting date for the remaining 50% of the 2025 RSU grant. |
Recommendation
holdThis Form 4 filing details routine executive compensation activities, including the vesting of restricted stock units and a new RSU grant, along with shares withheld for tax obligations. Such transactions are standard for executive compensation and do not provide new fundamental information to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing does not present a catalyst for significant price movement or a change in the company's underlying value proposition.
Keywords
Varex Imaging, VREX, Andrew Hartmann, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.